AmCad BioMed Market Cap

AmCad BioMed has a market cap or net worth of 820.16 million as of March 9, 2026. Its market cap has decreased by -38.33% in one year.

Market Cap

820.16M

Enterprise Value

533.09M

Revenue

30.44M

Ranking

n/a

PE Ratio

n/a

Stock Price

12.95

Market Cap Chart

Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 820.16M, a decrease of -9.44%. That is a compound annual growth rate of -0.81%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	820.16M	-11.90%
Dec 31, 2025	930.99M	-34.23%
Dec 31, 2024	1.42B	-0.45%
Dec 29, 2023	1.42B	67.51%
Dec 30, 2022	848.88M	-17.57%
Dec 30, 2021	1.03B	0.26%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Radiant Innovation	830.95M
PlexBio	828.16M
S&S Healthcare Holding	987.22M
Wiltrom	1.15B
Health & Life	592.60M
AViTA	1.20B
Bioptik Technology Incorporation	1.52B
Taiwan Advanced Nanotech	447.15M

Market Cap Rankings